BAY 41-2272
Cat. No.:YN320581
CAS No. :256376-24-6
产品名称: | BAY 41-2272 |
CAS No.: | 256376-24-6 |
Chemical Name: | 5-cyclopropyl-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-4-pyrimidinamine |
Synonyms: | BAY 41-2272, 256376-24-6, UNII-34A162J6WB, IN1523, BAY-41-2272, 3-(4-Amino-5-cyclopropylpyrimidin-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine |
分子量: | 360.39 |
分子式: | C₂₀H₁₇FN₆ |
SMILES: | NC1=NC(C2=NN(CC3=CC=CC=C3F)C4=NC=CC=C42)=NC=C1C5CC5 |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | BAY 41-2272是一种可溶性鸟苷酸环化酶 (sGC) 活化剂。 |
IC50和靶点: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Derbyshire, E.R., and Marletta, M.A.Structure and regulation of soluble guanylate cyclaseAnnu. Rev. Biochem.81,533-559(2012)
Stasch, J.P., Becker, E.M., Alonso-Alija, C., et al.NO-independent regulatory site on soluble guanylate cyclaseNature410,212-215(2001)
Evgenov, O.V., Pacher, P., Schmidt, P.M., et al.NO-independent stimulators and activators of soluble guanylate cyclase: Discovery and therapeutic potentialNat. Rev. Drug Discov.5(9),755-768(2006)
Stasch, J.P., Alonso-Alija, C., Apeler, H., et al.Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: In vitro studiesBr. J. Pharmacol.135,333-343(2002)